Sharda Cropchem · risk themes across the available quarters.
Bear-case history
EUR/USD movement created significant P&L volatility with forex gain dropping to Rs 7.5 crore from Rs 73.1 crore YoY, causing reported PAT to understate underlying operating performance. Analysts raised concerns about reporting transparency.
LATAM gross margins declined sharply to 16.9% from 28% YoY despite strong revenue growth. Management attributed this to mix and competitive dynamics, not fully explaining the pressure.
Analyst raised concerns that registrations added in past 3 years (less than 100) are significantly lower than the ~300 added in FY21-23, potentially impacting future growth pipeline. Management cited regulatory uncertainties as explanation.
Depreciation and amortization run-rate is trending toward Rs 370-375 crore for FY27 versus Rs 325 crore last year due to intangible capex (registration costs) amortization, which could pressure future earnings.
Chairman explicitly stated registration process is full of uncertainties with timelines ranging from 1 year to 6-7 years due to changing government requirements. This makes FY27 guidance on revenue from new registrations inherently unpredictable.
Management acknowledged that price realizations are quite down compared to pre-COVID levels, though sourcing costs have also declined. While prices are moving up gradually, the pace is slow and magnitude of recovery is uncertain.
Chairman deflected questions on China export rebate policy changes, stating Chinese government information is not transparent to foreigners. Though management claimed no current impact, any tightening of agrochemical exports from China could disrupt supply chain.
NAFTA region witnessed year-on-year degrowth in Q3, attributed to unusual and unpredictable climate conditions. Management provided no clear recovery timeline for this important market contributing ~23.5% gross margin.